TBA (last known deadline was March 2, 2011)
The New Therapy Grants Program is a unique partnership between two leading epilepsy non-profit organizations, the Epilepsy Therapy Project and the Epilepsy Foundation. The mission of the New Therapy Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided for grants supporting the research and development of new therapies in both academic and commercial settings worldwide. New Therapy Grants Program The New Therapy Grants Program seeks to advance the development of specific new therapies including new medicines and therapeutic devices. Consistent with the theme of translational research, all grant proposals must demonstrate a clear path from the lab to the patient. Other areas of consideration include but are not limited to: * Seed funding for preliminary and targeted work deemed necessary to explore novel therapeutic approaches * Projects which if successful offer a clear path to downstream development * Proposals that support the commercialization of exceptional academic research projects * Research to bring new approaches and therapy to children Key issues for reviewers are whether the program could lead to a new therapy that is approvable by FDA or meet other criteria for reimbursement: major roadblocks to getting new therapies to patients. Preference will be given to proposals that already have a commercial partner engaged to assist with development and to proposals that have committed or matched funding from the sponsoring institution, commercial partner or other third party source. Proposals for research originating from outside the United States are welcome.